3-(benzyloxy)cyclobutanamine is useful intermediate for synthesis of pharmacologically active molecules, e.g. imidazole derivatives for cdk5,cdk2 and GSK-3 inhibitors, heteroaryloxycarbocyclyl or heterobicyclic compounds for treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, Huntington's Disease, and the like.